| 产品详情 |
| Edit |   |
|---|
| Product Name | KLK2, Recombinant, Human |
|---|
| Description | Purity ~85% (SDS-PAGE, reducing conditions). Kallikrein 2 (KLK2) is a secreted serine protease that is highly expressed in the human prostate gland. It is also known as the prostatespecific glandular kallikrein. The enzyme is highly specific for cleavage after arginine residues. KLK2 is able to activate the urokinasetype plasminogen activator. KLK2 is inhibited by serpins such as protein C inhibitor, antichymotrypsin, and plasminogen activator inhibitor 1. KLK2 is structurally related to KLK3, the prostatespecific antigen (PSA). Like PSA, KLK2 is considered to be a biomarker for prostate cancer. Source: Murine myeloma cell line, NS0-derived Met1Pro261, with a Cterminal 10His tag. SDS-PAGE: 34kD & 15-18kD, reducing conditions Activity: Measured by its ability to cleave a flourogenic peptide substrate ProPheArg7amido4methylcoumarin (PFR-AMC). Specific Activity: ≥125pmoles/min/ug. Endotoxin Level: ≤1EU/1ug (LAL) |
|---|
| Size | 10ug |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | KLK2, Recombinant, Human (Kallikrein-2, Glandular Kallikrein-1, hGK-1, Tissue Kallikrein-2, Kallikrein 2) |
|---|
| Gene, Accession, CAS # | SwissProt: P20151 |
|---|
| Catalog # | K0005-05X |
|---|
| Price | |
|---|
| Order / More Info | KLK2, Recombinant, Human from UNITED STATES BIOLOGICAL |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|